Yingxin Xu
机构:Sun Yat-sen University, Regeneron (United States)
发表论文 113 篇 · 总被引 2569 次 · h-index 19
代表论文
- Enhancing systematic literature reviews with generative artificial intelligence: development, applications, and performance evaluation (2025 · Journal of the American Medical Informatics Association · 被引 57)
- Dupilumab Versus Mepolizumab for Chronic Rhinosinusitis With Nasal Polyposis: An Indirect Treatment Comparison (2024 · The Journal of Allergy and Clinical Immunology In Practice · 被引 31)
- Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison (2025 · Dermatology and Therapy · 被引 9)
- Indirect Comparison of Linvoseltamab Versus Teclistamab for the Treatment of Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (2025 · Clinical Lymphoma Myeloma & Leukemia · 被引 8)
- Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials (2025 · Ophthalmology and Therapy · 被引 7)
- Multi-functional antibacterial bio-Patch based on modified hyaluronic acid for skin infected incision repair (2025 · International Journal of Biological Macromolecules · 被引 4)